Oxford Lane Taps Market for $60M With 8.25% Preferred Stock Yield

GREENWICH, Conn. – March 13, 2026 – Oxford Lane Capital Corp. (NASDAQ: OXLC), a prominent investment firm focused on Collateralized Loan Obligations (CLOs), announced today it has priced a public offering of $60 million in new preferred stock, a move that provides a significant capital injection as the company navigates recent financial headwinds.

The offering consists of 2,400,000 shares of a newly designated 8.25% Series 2031 Term Preferred Stock, priced at $25 per share. The company has also granted the underwriters, led by joint book-runners Lucid Capital Markets, LLC and Piper Sandler & Co., a 30-day option to purchase up to 360,000 additional shares, which could raise total gross proceeds to $69 million. The shares are expected to be delivered around March 20, 2026, and the company has applied to list them on the NASDAQ Global Select Market.

A Strategic Move to Shore Up the Balance Sheet

While new capital raises are common, the timing and context of Oxford Lane’s offering suggest a strategic maneuver to bolster its financial foundation. The company stated the net proceeds will be used "to repay outstanding indebtedness (which may include our existing preferred stock or unsecured notes) and/or for general working capital purposes." This broad mandate gives the firm flexibility in managing its liabilities.

The move comes at a critical time for the closed-end fund. Recent financial reports have revealed significant pressure on its portfolio, with its net asset value (NAV) per common share falling sharply from $19.19 on September 30, 2025, to $15.51 as of December 31, 2025. This decline has been mirrored in its common stock performance, which has fallen over 40% in the last six months and recently traded near its 52-week low.

Compounding investor concerns, the company recently announced a cut to its monthly common stock dividend, a move that sent its share price tumbling further. Financial data underscores the challenges, revealing a current ratio of 0.61, indicating short-term obligations exceed liquid assets, and a deeply negative free cash flow yield. This offering appears to be a direct response to these pressures, aimed at injecting much-needed liquidity and deleveraging the balance sheet to create a more stable financial footing. By potentially refinancing higher-cost debt or preferred shares, Oxford Lane could lower its overall cost of capital and improve its financial flexibility moving forward.

What the 8.25% Yield Means for Investors

For income-seeking investors, the new Series 2031 Term Preferred Shares present a compelling, albeit not risk-free, proposition. The fixed 8.25% annual dividend, paid monthly, stands out in a market where investment-grade preferred securities are yielding closer to 6-7%. This premium yield reflects the specialized and more volatile nature of Oxford Lane's underlying CLO investments.

As a "term" preferred stock, the security has a mandatory redemption date in 2031, providing investors with a defined investment horizon, unlike perpetual preferreds. In the corporate capital structure, these new shares rank senior to the company's common stock, meaning preferred shareholders must be paid their dividends before any dividends can be distributed to common stockholders. They also have a priority claim on assets in the event of liquidation.

However, they are subordinate to the company's outstanding unsecured notes, which total approximately $500 million. This means that in a worst-case scenario, noteholders would be paid before preferred shareholders. The shares are also not convertible into common stock, limiting potential upside to the fixed dividend payments and the return of principal at maturity or redemption. Investors are therefore weighing a high-income stream against the inherent risks tied to the performance of Oxford Lane's CLO equity and debt portfolio, which has shown significant volatility.

A Barometer for the CLO Market

Beyond Oxford Lane's internal finances, this capital raise serves as an interesting barometer for the broader CLO market itself. The firm's ability to attract $60 million in fresh capital, particularly through a security underwritten by established players like Piper Sandler, signals a degree of market confidence in the viability of the CLO asset class, or at least in Oxford Lane's ability to manage it.

The outlook for the CLO market in 2026 is mixed. While some analysts predict strong issuance driven by refinancing and reset activity, others are more cautious, citing concerns over deteriorating credit quality and widening performance gaps between top-tier and lower-tier managers. The path of interest rates remains a critical variable; further cuts by the Federal Reserve could spur more loan origination and invigorate primary CLO creation.

By securing this new funding, Oxford Lane positions itself to act on opportunities within this complex environment. The capital could be deployed to acquire discounted CLO tranches or to refinance its own structures on more favorable terms. The involvement of Lucid Capital Markets as a book-runner is also noteworthy, as the firm initiated coverage on Oxford Lane in late 2024 with a "Buy" rating, citing its experienced management and long-term strategy. This successful offering may therefore be interpreted as a vote of confidence, not just from the underwriters, but from a segment of the investment community that believes the potential rewards in the CLO space outweigh the well-documented risks. The initial trading performance of the new preferred stock will be watched closely as a measure of this investor appetite.